| Style | Citing Format |
|---|---|
| MLA | Mousavifatemi K, et al.. "Enterobius Vermicularis Infection of the Lung Associated With the Use of Ibrutinib in a Patient With Chronic Lymphocytic Leukemia." American Journal of Therapeutics, vol. 28, no. 6, 2021, pp. E801-E803. |
| APA | Mousavifatemi K, Mousavi SA, Khosravi S, Maleki N (2021). Enterobius Vermicularis Infection of the Lung Associated With the Use of Ibrutinib in a Patient With Chronic Lymphocytic Leukemia. American Journal of Therapeutics, 28(6), E801-E803. |
| Chicago | Mousavifatemi K, Mousavi SA, Khosravi S, Maleki N. "Enterobius Vermicularis Infection of the Lung Associated With the Use of Ibrutinib in a Patient With Chronic Lymphocytic Leukemia." American Journal of Therapeutics 28, no. 6 (2021): E801-E803. |
| Harvard | Mousavifatemi K et al. (2021) 'Enterobius Vermicularis Infection of the Lung Associated With the Use of Ibrutinib in a Patient With Chronic Lymphocytic Leukemia', American Journal of Therapeutics, 28(6), pp. E801-E803. |
| Vancouver | Mousavifatemi K, Mousavi SA, Khosravi S, Maleki N. Enterobius Vermicularis Infection of the Lung Associated With the Use of Ibrutinib in a Patient With Chronic Lymphocytic Leukemia. American Journal of Therapeutics. 2021;28(6):E801-E803. |
| BibTex | @article{ author = {Mousavifatemi K and Mousavi SA and Khosravi S and Maleki N}, title = {Enterobius Vermicularis Infection of the Lung Associated With the Use of Ibrutinib in a Patient With Chronic Lymphocytic Leukemia}, journal = {American Journal of Therapeutics}, volume = {28}, number = {6}, pages = {E801-E803}, year = {2021} } |
| RIS | TY - JOUR AU - Mousavifatemi K AU - Mousavi SA AU - Khosravi S AU - Maleki N TI - Enterobius Vermicularis Infection of the Lung Associated With the Use of Ibrutinib in a Patient With Chronic Lymphocytic Leukemia JO - American Journal of Therapeutics VL - 28 IS - 6 SP - E801 EP - E803 PY - 2021 ER - |